|
1
|
van Spronsen FJ, Blau N, Harding C,
Burlina A, Longo N and Bosch AM: Phenylketonuria. Nat Rev Dis
Primers. 7(36)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Loeber JG: Neonatal screening in Europe;
the situation in 2004. J Inherit Metab Dis. 30:430–438.
2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
National Institutes of Health Consensus
Development Panel: national institutes of health consensus
development conference statement. Phenylketonuria: Screening and
management, October 16-18, 2000. Pediatrics. 108:972–982.
2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gu X, Wang Z, Ye J, Han L and Qiu W:
Newborn screening in China: Phenylketonuria, congenital
hypothyroidism and expanded screening. Ann Acad Med Singap. 37
(Suppl 12):S107–S104. 2008.PubMed/NCBI
|
|
5
|
Mitchell JJ, Trakadis YJ and Scriver CR:
Phenylalanine hydroxylase deficiency. Genet Med. 13:697–707.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Blau N, Hennermann JB, Langenbeck U and
Lichter-Konecki U: Diagnosis, classification, and genetics of
phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol
Genet Metab. 104 (Suppl 1):S2–S9. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yang Y and Ye Y: Subspecial Group of
Endocrine, Hereditary and Metabolic Diseases; Society of
Pediatrics, Chinese Medical Association; Newborn Screening
Committee of Professional Society of Birth Defect Prevention and
Control; Chinese Assocation of Preventive Medical. Consensus about
the diagnosis and treatment of hyperphenylalaninemia. Zhonghua Er
Ke Za Zhi. 52:420–425. 2014.PubMed/NCBI(In Chinese).
|
|
8
|
Subspecialty Group of Newborn Screening,
Society of Birth Defects Prevention and Control, Chinese Preventive
Medicine Association; Subspecialty Group of Clinical Nutrition, the
Society of Pediatrics, Chinese Medical Association; Subspecialty
Committee of Clinical Biochemistry and Genetics, the Society of
Medical Genetics, Chinese Medical Doctor Association; Subspecialty
Group of Clinical Genetics. Consensus statement on dietary
treatment and nutritional management for phenylalanine hydroxylase
deficiency. Zhonghua Er Ke Za Zhi. 57:405–409. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
9
|
Perko D, Groselj U, Cuk V, Iztok Remec Z,
Zerjav Tansek M, Drole Torkar A, Krhin B, Bicek A, Oblak A,
Battelino T and Repic Lampret B: Comparison of tandem mass
spectrometry and the fluorometric method-parallel phenylalanine
measurement on a large fresh sample series and implications for
newborn screening for phenylketonuria. Int J Mol Sci.
24(2487)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Feng S, Mei J, Yang L, Luo P, Wang X, Wang
Y, Yao J, Cui L, Pan L, Wang Z and Xin L: Benzene derivatives from
ink lead to false positive results in neonatal
hyperphenylalaninemia screening with ninhydrin fluorometric method.
Int J Neonatal Screen. 6(14)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Groselj U, Murko S, Zerjav Tansek M, Kovac
J, Trampus Bakija A, Repic Lampret B and Battelino T: Comparison of
tandem mass spectrometry and amino acid analyzer for phenylalanine
and tyrosine monitoring--implications for clinical management of
patients with hyperphenylalaninemia. Clin Biochem. 48:14–18.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Slim K, Nini E, Forestier D, Kwiatkowski
F, Panis Y and Chipponi J: Methodological index for non-randomized
studies (minors): Development and validation of a new instrument.
ANZ J Surg. 73:712–716. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ma Y, Huo X, Kong S, Xu W, Zhao W and Zhu
M: A review about C-TIRADS, ACR-TIRADS, and K-TIRADS combined with
real-time tissue elastography to diagnose thyroid nodules. Discov
Med. 35:1–10. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Qiu X, Zhao P, Luo J, Li G, Deng L, Zeng
Y, Xu L and Zhou J: Biochemical and molecular features of
tetrahydrobiopterin deficiency in Fujian Province, southeastern
China. Front Genet. 14(1250568)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang X, Wang Y, Ma D, Zhang Z, Li Y, Yang
P, Sun Y and Jiang T: Neonatal screening and genotype-phenotype
correlation of hyperphenylalaninemia in the Chinese population.
Orphanet J Rare Dis. 16(214)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang T, Ma J, Zhang Q, Gao A, Wang Q, Li
H, Xiang J and Wang B: Expanded newborn screening for inborn errors
of metabolism by tandem mass spectrometry in Suzhou, China: Disease
spectrum, prevalence, genetic characteristics in a Chinese
population. Front Genet. 10(1052)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li X, He J, He L, Zeng Y, Huang X, Luo Y
and Li Y: Spectrum analysis of inherited metabolic disorders for
expanded newborn screening in a Central Chinese population. Front
Genet. 12(763222)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yuan X, Zhu J, Liu H, Xiang L, Yao Y, Li
Q, Deng K and Li X: Birth prevalence of tetrahydrobiopterin
deficiency in China: Data from the national newborn screening
program, 2013-2019. J Pediatr Endocrinol Metab. 34:835–841.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang R, Shen N, Ye J, Han L, Qiu W, Zhang
H, Liang L, Sun Y, Fan Y, Wang L, et al: Mutation spectrum of
hyperphenylalaninemia candidate genes and the genotype-phenotype
correlation in the Chinese population. Clin Chim Acta. 481:132–138.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lin Y, Lin W, Su R, Zheng Z, Fu Q and Wang
G: Newborn screening and genetic features of patients with
hyperphenylalaninemia in a southern Chinese population. Clin Chim
Acta. 535:13–18. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang X, He Y, Jiang Y, Feng X, Zhang G,
Xia Z and Zhou Y: Screening and mutation analysis of
hyperphenylalaninemia in newborns from Xiamen, China. Clin Chim
Acta. 498:161–166. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ramalho AR, Ramalho RJ, Oliveira CR,
Magalhães MM, Santos EG, Sarmento PM, Matos DO, Oliveira MC,
Oliveira AL and Aguiar-Oliveira MH: Evaluation of effectiveness and
outcome of PKU screening and management in the State of Sergipe,
Brazil. Arq Bras Endocrinol Metabol. 58:62–67. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Steinfeld R, Kohlschütter A, Ullrich K and
Lukacs Z: Efficiency of long-term tetrahydrobiopterin monotherapy
in phenylketonuria. J Inherit Metab Dis. 27:449–453.
2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Aoki K: Long term follow-up of patients
with inborn errors of metabolism detected by the newborn screening
program in Japan. Southeast Asian J Trop Med Public Health. 34
(Suppl 3):S19–S23. 2003.PubMed/NCBI
|
|
25
|
Kaye CI: Committee on Genetics. Accurso F,
La Franchi S, Lane PA, Hope N, Sonya P, G Bradley S and Michele
ALP: Newborn screening fact sheets. Pediatrics. 118:e934–e963.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lin Y, Zheng Q, Zheng T, Zheng Z, Lin W
and Fu Q: Expanded newborn screening for inherited metabolic
disorders and genetic characteristics in a southern Chinese
population. Clin Chim Acta. 494:106–111. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Opladen T, López-Laso E,
Cortès-Saladelafont E, Pearson TS, Sivri HS, Yildiz Y, Assmann B,
Kurian MA, Leuzzi V, Heales S, et al: Consensus guideline for the
diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.
Orphanet J Rare Dis. 15(126)2020.PubMed/NCBI View Article : Google Scholar
|
